Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities.

Christoph WürnschimmelMike WenzelClaudia Collà RuvoloLuigi NoceraZhe TianFred SaadAlberto BrigantiShahrokh F ShariatPhilipp MandelFelix K H ChunDerya TilkiMarkus GraefenPierre I Karakiewicz

Published in: World journal of urology (2021)

In the setting of mPCa treated with EBRT, Asians exhibit lower CSM than Caucasians, African-Americans and Hispanic/Latinos. This observation may warrant consideration in prognostic stratification schemes for newly diagnosed mPCa patients.

Keyphrases

newly diagnosed
prostate cancer
end stage renal disease
squamous cell carcinoma
small cell lung cancer
chronic kidney disease
ejection fraction
radical prostatectomy
radiation therapy
early stage
prognostic factors
locally advanced
free survival
patient reported